New Programs Aim to Improve Implementation of Cardiovascular Interventions

Author(s):

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP,Aislinn Antrim, Managing Editor

Ralph Riello, PharmD, BCPS, a board-certified clinical pharmacy specialist at the Yale University School of Medicine, discusses challenges in implementation for novel cardiovascular treatments and interventions.

Ralph Riello, PharmD, BCPS, a board-certified clinical pharmacy specialist at Yale University School of Medicine, discusses challenges in implementation for novel cardiovascular treatments and interventions. In his work, Riello has researched the use of proactive messaging to providers to better implement new treatments, finding success with this approach.